A patient in the lab®

HUB Organoids predict patient response to treatment.

Our technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.

find out more

What can we do for you?


Model and assay development

Decipher the complexity of human disease working with the pioneers of adult stem cell-derived organoid technology

Drug development services

Reduce drug attrition with patient-derived organoid drug screening and predict patient response with clinical trials in a dish®


Access our biobank

1000s of established models – from both normal and diseased tissue

License HUB Organoid Technology

License HUB Organoid Technology

Bring HUB Organoid Technology and knowhow in-house

We are trusted by global leaders

to bring the next-generation therapeutics to patients.


Bring HUB Organoid Technology and knowhow in-house

apply for a license

Outsource your drug development program

discover our sevices

Latest News


First clinical candidate developed using HUB Organoids makes it to clinical trials within five years

read more


Applications to immuno-oncology drug development

download now


Challenges in preclinical modeling of cancer immunity

read more


Have any questions?

contact us